Edison Investment Research is terminating coverage on BCI Minerals (BCI) and Sunesis Pharmaceuticals (SNSS). Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.

29 Sep 2020
Sunesis Pharmaceuticals - Termination of coverage

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Sunesis Pharmaceuticals - Termination of coverage
Edison Investment Research is terminating coverage on BCI Minerals (BCI) and Sunesis Pharmaceuticals (SNSS). Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.